India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Prim Care Diabetes. 2022 Jun;16(3):440-444. doi: 10.1016/j.pcd.2022.02.004. Epub 2022 Mar 23.
To study the concordance in the incidence of type 2 diabetes (T2DM) between cohorts with prediabetes, selected either by oral glucose tolerance test (OGTT) or glycosylated haemoglobin (HbA1c) at two years in a real world situation.
Two cohorts with impaired glucose tolerance (IGT) were selected from the non-interventional arm of the Indian diabetes prevention programmes; a group selected by using OGTT (Cohort 1, n = 498), another selected based on the HbA1c criterion (Cohort 2, n = 504). Clinical and biochemical data collected for 24 months at 6 monthly intervals were used in assessing the cumulative incidence of T2DM using the respective diagnostic criteria. Intra and inter group comparisons were analysed using appropriate statistical tests. A multiple logistic regression analysis was used to identify the variables significantly associated with the incidence of diabetes.
Incidence of diabetes in both cohorts were similar at 12 and 24 months with either of the two criteria (25.3% with glucose and 27.5% with HbA1c, p = 0.41 at 24 months). The multivariate analysis confirmed the results. Only baseline waist circumference was positively associated with the incidence.
Both OGTT and HbA1c have similar utility and validity in identifying persons with IGT. Persons identified with either of the criterion had similar incidence of T2DM among Asian Indians.
研究在真实世界环境中,通过口服葡萄糖耐量试验(OGTT)或糖化血红蛋白(HbA1c)在两年内选择的糖尿病前期队列中 2 型糖尿病(T2DM)的发病率是否一致。
从印度糖尿病预防计划的非干预组中选择了两个葡萄糖耐量受损(IGT)队列;一组通过 OGTT 选择(队列 1,n=498),另一组根据 HbA1c 标准选择(队列 2,n=504)。使用相应的诊断标准,在 24 个月内每 6 个月收集一次临床和生化数据,以评估 T2DM 的累积发病率。使用适当的统计检验分析组内和组间比较。使用多元逻辑回归分析来确定与糖尿病发病率显著相关的变量。
使用两种标准时,两个队列的糖尿病发病率在 12 个月和 24 个月时均相似(葡萄糖组为 25.3%,HbA1c 组为 27.5%,24 个月时 p=0.41)。多变量分析证实了这一结果。只有基线腰围与发病率呈正相关。
OGTT 和 HbA1c 在识别 IGT 人群方面具有相似的效用和有效性。无论使用哪种标准识别出的人,其亚洲印度人中 T2DM 的发病率相似。